Today, Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases, announced that they have entered into a strategic partnership with Genesis Research.
Aug 31, 2022 | hitconsultant.netSyapse selected Infor to help collect, analyze, and leverage massive amounts of pertinent data that can have significant consequences for patients and healthcare providers.
Jan 1, 2022 | prnewswire.comSyapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, announced a collaboration with Main Line Health, home to four of the Philadelphia region’s most respected acute care hospitals.
Jan 1, 2022 | yahoo.comOncology-focused real-world evidence company Syapse wrapped up a $35 million growth funding round led by an affiliate of Innovatus Capital Partners.
Jan 1, 2022 | mobihealthnews.comSubsequent to the quarter, Syapse raised a total of $35 million in growth capital, including $1.6 million from Safeguard.
Jan 1, 2022 | marketscreener.comSyapse, a real-world evidence company that informs cancer care, announced a partnership with Bayhealth – central and southern Delaware’s largest healthcare system.
Jan 1, 2021 | hitconsultant.netSyapse launched in 2008 and has raised an estimated $39.6 million in funding, according to Crunchbase.
Jan 1, 2017 | bizjournals.com